Type 2 diabetes, definitions combined, including avohilmo

T2D_INCLAVO

No definition available.

Endpoint definition

FinnGen phenotype data

356077 individuals

diagram downward connector

Apply sex-specific rule None

356077

diagram downward connector
diagram bullet

Check conditions

not E4_DM1

346486

diagram downward connector
diagram bullet

Filter registries

Primary healthcare outpatient ICD-10: E11

37948

diagram downward connector

Check pre-conditions, main-only, mode, ICD version None

37948

diagram downward connector

Check minimum number of events None

37948

diagram downward connector
diagram bullet diagram downward connector

Include endpoints

54494

diagram downward connector
T2D_INCLAVO

Extra metadata

First used in FinnGen datafreeze DF5

Summary Statistics

Key figures

All Female Male
Number of individuals 54494 24128 30366
Unadjusted prevalence (%) 15.32 12.16 19.30
Mean age at first event (years) 60.42 59.25 61.36

Mortality

Follow-up Absolute risk HR [95% CI] p N
1998–2019 0.04 2.34 [2.12, 2.58] 4.4e-64 9157
15 years 0.01 1.65 [1.52, 1.80] 3.1e-31 4618
5 years 0.00 2.46 [2.28, 2.65] <1e-100 2316
1 year 0.00 4.59 [4.10, 5.15] <1e-100 814

Age distribution of first events

Year distribution of first events

Cumulative Incidence

Correlations

Index endpoint: T2D_INCLAVO – Type 2 diabetes, definitions combined, including avohilmo
GWS hits:

Survival analyses between endpoints

Plot

before Type 2 diabetes, definitions combined, including avohilmo
after Type 2 diabetes, definitions combined, including avohilmo

loading spinner Loading survival analyses plot

Drugs most likely to be purchased after Type 2 diabetes, definitions combined, including avohilmo